The safety evaluation of endoscopic biopsy against patients receiving anticoagulatns and antiplatelet agents.
Not Applicable
- Conditions
- Outpatients undergoing gastrointestinal endoscopy during antithrombotic therapy
- Registration Number
- JPRN-UMIN000003750
- Lead Sponsor
- Department of Endoscopy and Endoscopic Surgery, Graduate School of Medicine, The University of Tokyo.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
(A)Strong possibility of lesions requiring more invasive procedures than biopsy. (B)During hospitalization. (C)Other severe comorbidities. (D)During anticancer chemotherapy. (E)Severe hematological, hepatological, or renal disorder accompanied with hemorrhagic tendency. (F)INR exceeding the upper limit shown in the guideline by Japanese circulation society.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method